Corinne Jenkins

Stock Analyst at Goldman Sachs

(1.76)
# 3,081
Out of 4,853 analysts
62
Total ratings
44.19%
Success rate
-3.21%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Corinne Jenkins

Rhythm Pharmaceuticals
Dec 5, 2024
Maintains: Buy
Price Target: $59$66
Current: $66.18
Upside: -0.27%
TG Therapeutics
Nov 5, 2024
Maintains: Neutral
Price Target: $20$22
Current: $39.30
Upside: -44.02%
Fulcrum Therapeutics
May 14, 2024
Upgrades: Buy
Price Target: $6$15
Current: $7.11
Upside: +110.97%
IDEAYA Biosciences
May 13, 2024
Maintains: Buy
Price Target: $53$46
Current: $21.10
Upside: +118.01%
Roivant Sciences
Apr 3, 2024
Maintains: Buy
Price Target: $16$18
Current: $11.20
Upside: +60.71%
Geron
Mar 15, 2024
Maintains: Buy
Price Target: $4$5
Current: $1.56
Upside: +220.51%
Altimmune
Jan 24, 2024
Reinstates: Neutral
Price Target: $13
Current: $5.46
Upside: +138.10%
Harmony Biosciences Holdings
Jan 9, 2024
Maintains: Sell
Price Target: $25$28
Current: $35.03
Upside: -20.07%
SpringWorks Therapeutics
Nov 29, 2023
Maintains: Buy
Price Target: $47$52
Current: $46.80
Upside: +11.11%
BioXcel Therapeutics
Aug 15, 2023
Maintains: Neutral
Price Target: $192$64
Current: $1.53
Upside: +4,083.01%
Maintains: Buy
Price Target: $27$23
Current: $1.02
Upside: +2,154.90%
Maintains: Buy
Price Target: $25$21
Current: $1.56
Upside: +1,246.15%
Maintains: Buy
Price Target: $9$14
Current: $3.54
Upside: +295.48%
Maintains: Neutral
Price Target: $9$8
Current: $29.60
Upside: -72.97%
Initiates: Neutral
Price Target: $16
Current: $0.34
Upside: +4,589.33%